WA-KYMETA/COMTECH-TEL
Kymeta, the communications company making mobile global, and Comtech Telecommunications Corp. (NASDAQ: CMTL), a leading global provider of next-generation 911 emergency systems and secure wireless communications technologies, announced today a technology and business development partnership. As a result, Kymeta has diversified its service offerings via network compatibility with Comtech’s UHP-200 Universal Satellite Router and the Kymeta™ u8 terminal, and Comtech has expanded distribution of its recently acquired UHP product line and strengthened its ability to offer integrated VSAT solutions to its customers.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210825005235/en/
Comtech’s certified UHP platform will enable new and existing Department of Defense (DoD) and commercial customers to operate the state-of-the-art Kymeta u8 for cost-effective and seamless communication solutions through its VSAT router technology. Kymeta will begin offering UHP-based services in North America.
The UHP-200 is an extremely fast VSAT router with aggregate throughput up to 450 Mbps and powerful UHP-real-time operating system. Its small size, low power consumption, and low count of active electronic components ensure the highest reliability with over 200,000 hours mean time between failures. UHP’s disruptive TDMA technology can result in a 20% efficiency advantage over other TDMA solutions. When paired with Kymeta’s next-generation solutions, government and commercial users will have access to efficient operating capabilities on the UHP network using the Kymeta u8.
Kymeta technology is uniquely positioned to meet the demand for mobile broadband, providing internet access via satellite or hybrid satellite-cellular networks on a user-defined basis to enable connectivity while on the move and on the pause. When combined with Kymeta connectivity offerings and back-end support suite of services, Kymeta Connect™, customers have unique access to an experience and product that no other satellite antenna company offers today.
“Kymeta continues to adapt, move, and grow in the market and we are excited to continue diversifying and strengthening our partnerships,” said Bill Marks, EVP and Chief Development Officer of Kymeta. “With an increased demand for UHP-connected services particularly in North America, this strategic technology partnership with Comtech will further enhance communications and offer new capabilities when and wherever needed.”
“With end-markets for high-speed satellite-based networks growing, this partnership is a significant step in enhancing our solution offerings,” said Dr. Vagan Shakhgildian, President of Comtech Satellite Network Technologies, Inc. - Commercial Group. “We are thrilled to collaborate with a forward-thinking company like Kymeta to provide service to end users with the quality and reassurance they expect from our innovative companies.”
This follows Kymeta’s recent announcement with Comtech to broaden its network offerings for the Kymeta u8 terminal through interoperability with Comtech’s SLM-5650B modem and Comtech’s March 2021 announcement to acquire UHP Networks Inc.
About Kymeta
Kymeta is unlocking the potential of broadband satellite connectivity, combined with cellular networks, to satisfy the overwhelming demand for comms on the move and making mobile global. Lepton Global Solutions, a Kymeta company, hosts the company’s satellite connectivity solutions and offers unique, complete, and turnkey bundled solutions to the market based on best-in-class technologies and tailored customer-centric services that meet and exceed customer mission requirements. These solutions in tandem with the company’s flat-panel satellite antenna, the first of its kind, and Kymeta Connect™ services provide revolutionary mobile connectivity on satellite and hybrid satellite-cellular networks to customers around the world. Backed by U.S. and international patents and licenses, the Kymeta terminal addresses the need for lightweight, slim, and high-throughput communication systems that do not require mechanical components to steer toward a satellite. Kymeta makes connecting easy – for any vehicle, vessel, or fixed platform.
Kymeta is a privately held company based in Redmond, Washington.
For more information, visit kymetacorp.com .
About Comtech
Comtech Telecommunications Corp. is a leading global provider of next-generation 911 emergency systems and critical wireless communications technologies to commercial and government customers around the world. Headquartered in Melville, New York and with a passion for customer success, Comtech designs, produces and markets advanced and secure wireless solutions to customers in more than 100 countries. For more information, please visit www.comtechtel.com .
Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company’s Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such Securities and Exchange Commission filings.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210825005235/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy5.11.2025 13:00:00 CET | Press release
Expands Registrar Corp’s reach to support over 75% of the global medical device market. Registrar Corp, a global leader in regulatory compliance and technology solutions and a Paine Schwartz Partners portfolio company, today announced the acquisition of CMC Medical Devices (CMC), a Spain-based provider of medical device regulatory, clinical, and compliance consulting services. The combination of Registrar Corp’s global network and CMC’s clinical and technical expertise creates a unified partner to help medical device and in vitro diagnostic (IVD) manufacturers bring products to market faster and with greater confidence. “We’re proud to welcome CMC Medical Devices to the Registrar Corp family,” said Raj Shah, CEO of Registrar Corp. “Together, we offer medical device manufacturers a single partner to navigate complex regulations and access the U.S., EU, and other key global markets—so they can focus on innovation rather than compliance.” “Joining Registrar Corp enables us to deliver even
Cybersecurity Leader Armis Closes $435 Million Round at $6.1 Billion Valuation5.11.2025 13:00:00 CET | Press release
In a pre-IPO round led by Growth Equity at Goldman Sachs Alternatives and with significant participation from CapitalG, Armis accelerates on the path to $1 billion in ARR and a public offering Armis, the cyber exposure management and security company, today announced a pre-IPO funding round of $435 million, bringing the company’s valuation to $6.1 billion. The round was led by Growth Equity at Goldman Sachs Alternatives with major participation from CapitalG, and was joined by new investor Evolution Equity Partners, alongside several existing investors. The investment round comes amid continued growth, with the company recently surpassing $300 million in Annual Recurring Revenue (ARR), growing over 50%. Armis has worked with over 40% of the Fortune 100, including 7 of the Fortune 10, and helps protect leading organizations around the globe, including manufacturers, airlines, financial services firms, healthcare institutions, and state and federal agencies. Yevgeny Dibrov, CEO and Co-Fo
Macrobond Selected by T. Rowe Price to Support Evolving Research and Investment Workflows5.11.2025 13:00:00 CET | Press release
Macrobond, the global platform for macroeconomic and financial data, has been selected by T. Rowe Price to support the continued evolution of its cross-asset research and systematic strategy workflows. As financial institutions look to strengthen data-driven decision-making, the need for scalable technology and integrated platforms has never been more critical. T. Rowe Price’s decision to implement Macrobond reflects a broader commitment to enhancing research workflows with modern, flexible solutions built for the pace and complexity of today’s investment landscape. Meeting the Demands of a Dynamic Environment The ability to integrate complex data sets, streamline analysis, and support automation were key factors in the selection process. Macrobond’s API and flexible data infrastructure provided a strong foundation for collaboration. “T. Rowe Price is continually investing in technology to improve the efficiency and quality of our research processes,” said Tae Kim, Head of Fixed Income
Compass Pathways to Participate in Stifel 2025 Healthcare Conference5.11.2025 12:30:00 CET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will participate in the Stifel 2025 Healthcare Conference in New York, NY at 10:40 am ET on Tuesday, November 11, 2025. A live audio webcast of these events will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable responses through the development of our investigational COMP36
Watchmaker Genomics Launches TAPS+, Expanding Multimodal Capabilities in Oncology Ahead of AMP 20255.11.2025 12:00:00 CET | Press release
- TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. - Preserves DNA integrity in challenging clinically relevant samples, including FFPE tissue and circulating tumor DNA (ctDNA). - Platform-agnostic chemistry enables seamless integration across sequencing systems. Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule. By capturing multiple biological dimensions in a single assay, TAPS+ delivers a richer, more comprehensive view of tumor biology, with the power to advance applications in translational oncology, early cancer detection, therapy response monitoring, fragmentomics, and minimal residual disease assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251105264633/en/ Watchmaker Genomics launches TAPS+, a next-gener
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
